| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.859 | 0.002 | 0.859 | Dopamine D2 agonist | 0.437 0.004 DBMET00941 0.618 0.003 DBMET00943 | ||
| 0.859 | 0.003 | 0.859 | Dopamine agonist | 0.515 0.004 DBMET00941 0.657 0.004 DBMET00943 | ||
| 0.755 | 0.001 | 0.755 | Dopamine autoreceptor agonist | 0.335 0.002 DBMET00941 0.184 0.003 DBMET00943 | ||
| 0.646 | 0.003 | 0.646 | Dopamine D1 antagonist | 0.224 0.009 DBMET00941 0.302 0.005 DBMET00943 | ||
| 0.633 | 0.004 | 0.633 | Dopamine antagonist | 0.225 0.016 DBMET00941 0.354 0.009 DBMET00943 | ||
| 0.632 | 0.004 | 0.632 | Dopamine D2 antagonist | 0.212 0.016 DBMET00941 0.35 0.009 DBMET00943 | ||
| 0.628 | 0.003 | 0.628 | Dopamine D3 agonist | 0.119 0.005 DBMET00941 0.288 0.004 DBMET00943 | ||
| 0.614 | 0.004 | 0.614 | 5 Hydroxytryptamine 1A agonist | 0.089 0.018 DBMET00941 0.339 0.005 DBMET00943 | ||
| 0.534 | 0.004 | 0.534 | 5 Hydroxytryptamine 1 agonist | 0.101 0.02 DBMET00941 0.295 0.007 DBMET00943 | ||
| 0.522 | 0.004 | 0.522 | Dopamine D3 antagonist | 0.213 0.01 DBMET00941 0.347 0.005 DBMET00943 | ||
| 0.484 | 0.004 | 0.484 | Alpha 2 adrenoreceptor antagonist | 0.228 0.014 DBMET00941 0.243 0.012 DBMET00943 | ||
| 0.412 | 0.027 | 0.412 | Cardiotonic | 0.234 0.093 DBMET00941 0.263 0.074 DBMET00943 | ||
| 0.374 | 0.005 | 0.374 | Dopamine D4 antagonist | 0.09 0.029 DBMET00941 0.119 0.022 DBMET00943 | ||
| 0.359 | 0.005 | 0.359 | Acetylcholine muscarinic antagonist | 0.18 0.03 DBMET00941 0.139 0.051 DBMET00943 | ||
| 0.351 | 0.006 | 0.351 | 5 Hydroxytryptamine agonist | 0.068 0.048 DBMET00941 0.23 0.012 DBMET00943 | ||
| 0.343 | 0.005 | 0.343 | Alpha 2a adrenoreceptor antagonist | 0.183 0.016 DBMET00941 0.281 0.007 DBMET00943 | ||
| 0.339 | 0.007 | 0.339 | Alpha 2b adrenoreceptor antagonist | 0.16 0.035 DBMET00941 0.328 0.007 DBMET00943 | ||
| 0.317 | 0.008 | 0.317 | 5 Hydroxytryptamine 1A antagonist | 0.068 0.047 DBMET00941 0.231 0.012 DBMET00943 | ||
| 0.273 | 0.004 | 0.312 | Adrenaline agonist | 0.312 0.004 DBMET00941 0.264 0.004 DBMET00943 | DBMET00941 | |
| 0.271 | 0.004 | 0.271 | Acetylcholine M3 receptor antagonist | 0.178 0.008 DBMET00941 0.071 0.031 DBMET00943 | ||
| 0.281 | 0.016 | 0.281 | Cholinergic antagonist | 0.13 0.065 DBMET00941 0.118 0.076 DBMET00943 | ||
| 0.301 | 0.039 | 0.301 | Sigma receptor agonist | 0.297 0.039 DBMET00943 | ||
| 0.273 | 0.012 | 0.273 | 5 Hydroxytryptamine 1 antagonist | 0.065 0.059 DBMET00941 0.22 0.015 DBMET00943 | ||
| 0.276 | 0.016 | 0.276 | Acetylcholine antagonist | 0.128 0.064 DBMET00941 0.115 0.075 DBMET00943 | ||
| 0.261 | 0.004 | 0.349 | Prolactin inhibitor | 0.125 0.035 DBMET00941 0.349 0.002 DBMET00943 | DBMET00943 | |
| 0.274 | 0.022 | 0.397 | NOS3 expression enhancer | 0.397 0.008 DBMET00941 0.372 0.01 DBMET00943 | DBMET00941 | |
| 0.23 | 0.031 | 0.23 | Acetylcholine M1 receptor antagonist | 0.152 0.072 DBMET00941 0.205 0.04 DBMET00943 | ||
| 0.208 | 0.016 | 0.219 | Alpha 2c adrenoreceptor antagonist | 0.09 0.076 DBMET00941 0.219 0.014 DBMET00943 | DBMET00943 | |
| 0.195 | 0.005 | 0.196 | Alpha 2 adrenoreceptor agonist | 0.135 0.008 DBMET00941 0.196 0.004 DBMET00943 | DBMET00943 | |
| 0.198 | 0.008 | 0.198 | 5 Hydroxytryptamine 1B antagonist | 0.069 0.042 DBMET00941 0.123 0.016 DBMET00943 | ||
| 0.21 | 0.032 | 0.21 | 5 Hydroxytryptamine antagonist | 0.1 0.079 DBMET00941 0.198 0.034 DBMET00943 | ||
| 0.281 | 0.102 | 0.309 | Antithrombotic | 0.276 0.106 DBMET00941 0.309 0.082 DBMET00943 | DBMET00943 | |
| 0.186 | 0.012 | 0.254 | Nitric-oxide synthase inhibitor | 0.254 0.005 DBMET00941 0.131 0.031 DBMET00943 | DBMET00941 | |
| 0.189 | 0.029 | 0.189 | Alpha adrenoreceptor antagonist | 0.09 0.063 DBMET00941 0.166 0.034 DBMET00943 | ||
| 0.164 | 0.01 | 0.164 | Sigma receptor antagonist | 0.059 0.028 DBMET00941 0.142 0.012 DBMET00943 | ||
| 0.269 | 0.114 | 0.355 | Vasodilator, peripheral | 0.201 0.175 DBMET00941 0.355 0.072 DBMET00943 | DBMET00943 | |
| 0.17 | 0.031 | 0.216 | Antiadrenergic | 0.122 0.045 DBMET00941 0.216 0.021 DBMET00943 | DBMET00943 | |
| 0.172 | 0.033 | 0.208 | Adenylate cyclase inhibitor | 0.159 0.04 DBMET00941 0.208 0.024 DBMET00943 | DBMET00943 | |
| 0.149 | 0.012 | 0.149 | 5 Hydroxytryptamine 1D antagonist | 0.058 0.051 DBMET00941 0.127 0.015 DBMET00943 | ||
| 0.166 | 0.031 | 0.214 | Adrenaline antagonist | 0.12 0.044 DBMET00941 0.214 0.021 DBMET00943 | DBMET00943 | |
| 0.239 | 0.116 | 0.362 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.362 0.032 DBMET00941 0.183 0.179 DBMET00943 | DBMET00941 | |
| 0.294 | 0.172 | 0.435 | 5 Hydroxytryptamine release inhibitor | 0.42 0.066 DBMET00941 0.435 0.058 DBMET00943 | DBMET00943 | |
| 0.139 | 0.018 | 0.191 | Alpha adrenoreceptor agonist | 0.095 0.03 DBMET00941 0.191 0.009 DBMET00943 | DBMET00943 | |
| 0.124 | 0.003 | 0.124 | Dopamine D1 agonist | 0.059 0.004 DBMET00941 0.073 0.004 DBMET00943 | ||
| 0.222 | 0.104 | 0.539 | Spasmolytic | 0.186 0.132 DBMET00941 0.539 0.019 DBMET00943 | DBMET00943 | |
| 0.12 | 0.004 | 0.251 | Dopamine D5 agonist | 0.145 0.003 DBMET00941 0.251 0.002 DBMET00943 | DBMET00943 | |
| 0.112 | 0.005 | 0.112 | Complement C5a chemotactic receptor antagonist | 0.036 0.015 DBMET00943 | ||
| 0.109 | 0.004 | 0.134 | Beta 2 adrenoreceptor agonist | 0.134 0.003 DBMET00941 0.09 0.005 DBMET00943 | DBMET00941 | |
| 0.169 | 0.064 | 0.178 | Neurotensin receptor agonist | 0.178 0.052 DBMET00943 | DBMET00943 | |
| 0.108 | 0.007 | 0.118 | Glucosylceramidase inhibitor | 0.111 0.006 DBMET00941 0.118 0.005 DBMET00943 | DBMET00943 | |
| 0.198 | 0.106 | 0.232 | Vasodilator | 0.232 0.08 DBMET00943 | DBMET00943 | |
| 0.115 | 0.022 | 0.115 | 5 Hydroxytryptamine 7 antagonist | 0.053 0.052 DBMET00943 | ||
| 0.126 | 0.034 | 0.126 | Folate antagonist | 0.116 0.043 DBMET00941 | ||
| 0.11 | 0.019 | 0.11 | Acetylcholine M2 receptor antagonist | 0.056 0.048 DBMET00943 | ||
| 0.116 | 0.027 | 0.12 | Alpha 2d adrenoreceptor antagonist | 0.12 0.023 DBMET00941 | DBMET00941 | |
| 0.091 | 0.009 | 0.121 | Beta 2 adrenoreceptor antagonist | 0.115 0.006 DBMET00941 0.121 0.006 DBMET00943 | DBMET00943 | |
| 0.109 | 0.028 | 0.109 | 5 Hydroxytryptamine 1F antagonist | 0.075 0.046 DBMET00943 | ||
| 0.21 | 0.13 | 0.258 | Lipoxygenase inhibitor | 0.258 0.095 DBMET00941 0.179 0.165 DBMET00943 | DBMET00941 | |
| 0.086 | 0.008 | 0.086 | Squalene epoxidase inhibitor | 0.057 0.024 DBMET00941 0.073 0.012 DBMET00943 | ||
| 0.094 | 0.019 | 0.135 | Beta adrenoreceptor antagonist | 0.104 0.015 DBMET00941 0.135 0.007 DBMET00943 | DBMET00943 | |
| 0.124 | 0.051 | 0.145 | Mucolytic | 0.145 0.035 DBMET00941 0.102 0.074 DBMET00943 | DBMET00941 | |
| 0.102 | 0.033 | 0.11 | Opioid kappa receptor antagonist | 0.092 0.043 DBMET00941 0.11 0.028 DBMET00943 | DBMET00943 | |
| 0.074 | 0.005 | 0.074 | 5 Hydroxytryptamine 1D agonist | 0.033 0.017 DBMET00941 0.043 0.013 DBMET00943 | ||
| 0.08 | 0.012 | 0.08 | Dopamine D5 antagonist | 0.036 0.035 DBMET00941 0.071 0.014 DBMET00943 | ||
| 0.072 | 0.005 | 0.104 | Beta adrenoreceptor agonist | 0.104 0.004 DBMET00941 0.071 0.005 DBMET00943 | DBMET00941 | |
| 0.123 | 0.057 | 0.138 | 5 Hydroxytryptamine 2 antagonist | 0.089 0.081 DBMET00941 0.138 0.049 DBMET00943 | DBMET00943 | |
| 0.1 | 0.037 | 0.126 | Inducible nitric-oxide synthase inhibitor | 0.126 0.023 DBMET00941 0.081 0.06 DBMET00943 | DBMET00941 | |
| 0.12 | 0.061 | 0.127 | 5 Hydroxytryptamine 2B antagonist | 0.127 0.054 DBMET00943 | DBMET00943 | |
| 0.082 | 0.03 | 0.166 | CXC chemokine 4 receptor antagonist | 0.056 0.045 DBMET00941 0.166 0.013 DBMET00943 | DBMET00943 | |
| 0.105 | 0.055 | 0.114 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET00941 0.108 0.05 DBMET00943 | DBMET00941 | |
| 0.115 | 0.065 | 0.126 | Estrogen antagonist | 0.117 0.061 DBMET00941 0.126 0.045 DBMET00943 | DBMET00943 | |
| 0.109 | 0.06 | 0.138 | Expectorant | 0.138 0.04 DBMET00941 0.099 0.069 DBMET00943 | DBMET00941 | |
| 0.155 | 0.108 | 0.172 | Anesthetic general | 0.172 0.093 DBMET00943 | DBMET00943 | |
| 0.074 | 0.028 | 0.266 | 5 Hydroxytryptamine 5A antagonist | 0.266 0.004 DBMET00943 | DBMET00943 | |
| 0.06 | 0.015 | 0.084 | Dopamine beta hydroxylase inhibitor | 0.084 0.005 DBMET00941 | DBMET00941 | |
| 0.227 | 0.185 | 0.372 | 15-Lipoxygenase inhibitor | 0.372 0.087 DBMET00941 | DBMET00941 | |
| 0.093 | 0.053 | 0.112 | Opioid antagonist | 0.09 0.057 DBMET00941 0.112 0.04 DBMET00943 | DBMET00943 | |
| 0.127 | 0.087 | 0.203 | Lipid peroxidase inhibitor | 0.203 0.04 DBMET00943 | DBMET00943 | |
| 0.098 | 0.06 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET00941 0.09 0.073 DBMET00943 | DBMET00941 | |
| 0.066 | 0.029 | 0.246 | 5 Hydroxytryptamine 5 antagonist | 0.246 0.004 DBMET00943 | DBMET00943 | |
| 0.112 | 0.08 | 0.112 | Aldehyde dehydrogenase inhibitor | |||
| 0.079 | 0.048 | 0.087 | Analgesic, opioid | 0.077 0.051 DBMET00941 0.087 0.04 DBMET00943 | DBMET00943 | |
| 0.091 | 0.06 | 0.121 | Glutamate release inhibitor | 0.121 0.021 DBMET00943 | DBMET00943 | |
| 0.161 | 0.132 | 0.225 | Free radical scavenger | 0.153 0.141 DBMET00941 0.225 0.08 DBMET00943 | DBMET00943 | |
| 0.051 | 0.023 | 0.051 | Oxytocin agonist | 0.037 0.035 DBMET00941 | ||
| 0.071 | 0.048 | 0.111 | CXC chemokine receptor antagonist | 0.111 0.02 DBMET00943 | DBMET00943 | |
| 0.037 | 0.015 | 0.037 | Prostaglandin D2 agonist | 0.031 0.021 DBMET00941 | ||
| 0.04 | 0.018 | 0.047 | AMPA receptor agonist | 0.047 0.011 DBMET00941 0.036 0.024 DBMET00943 | DBMET00941 | |
| 0.056 | 0.034 | 0.059 | Alpha tubulin antagonist | 0.059 0.032 DBMET00943 | DBMET00943 | |
| 0.068 | 0.047 | 0.08 | Opioid mu receptor antagonist | 0.08 0.04 DBMET00943 | DBMET00943 | |
| 0.097 | 0.082 | 0.136 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET00941 0.136 0.03 DBMET00943 | DBMET00943 | |
| 0.032 | 0.02 | 0.069 | Endothelial nitric-oxide synthase inhibitor | 0.069 0.005 DBMET00941 0.029 0.025 DBMET00943 | DBMET00941 | |
| 0.054 | 0.044 | 0.071 | Beta tubulin antagonist | 0.052 0.045 DBMET00941 0.071 0.034 DBMET00943 | DBMET00943 | |
| 0.072 | 0.063 | 0.093 | Estrogen receptor alpha antagonist | 0.093 0.032 DBMET00943 | DBMET00943 | |
| 0.103 | 0.094 | 0.133 | Sphingosine 1-phosphate receptor 2 agonist | 0.133 0.039 DBMET00941 0.117 0.06 DBMET00943 | DBMET00941 | |
| 0.076 | 0.07 | 0.086 | Caspase 7 inhibitor | 0.086 0.048 DBMET00941 | DBMET00941 | |
| 0.036 | 0.03 | 0.036 | TRPM8 blocker | |||
| 0.024 | 0.02 | 0.042 | Sigma 1 receptor antagonist | 0.042 0.012 DBMET00943 | DBMET00943 | |
| 0.026 | 0.023 | 0.028 | Bradykinin B2 receptor agonist | 0.028 0.021 DBMET00941 | DBMET00941 | |
| 0.018 | 0.015 | 0.046 | Alpha 2b adrenoreceptor agonist | 0.046 0.004 DBMET00943 | DBMET00943 | |
| 0.177 | 0.177 | 0.261 | 12-Lipoxygenase inhibitor | 0.261 0.103 DBMET00941 0.191 0.162 DBMET00943 | DBMET00941 | |
| 0.025 | 0.025 | 0.051 | Melatonin antagonist | 0.051 0.008 DBMET00943 | DBMET00943 | |
| 0.106 | 0.106 | 0.137 | Antibacterial (Helicobacter pylori) | 0.137 0.059 DBMET00941 | DBMET00941 | |
| 0.051 | 0.053 | 0.079 | Opioid delta receptor antagonist | 0.079 0.037 DBMET00943 | DBMET00943 | |
| 0.192 | 0.195 | 0.317 | Calpain 2 inhibitor | 0.299 0.115 DBMET00941 0.317 0.104 DBMET00943 | DBMET00943 | |
| 0.146 | 0.149 | 0.162 | Platelet antagonist | 0.155 0.139 DBMET00941 0.162 0.133 DBMET00943 | DBMET00943 | |
| 0.011 | 0.018 | 0.025 | NMDA receptor phencyclidine site antagonist | 0.025 0.005 DBMET00943 | DBMET00943 | |
| 0.058 | 0.065 | 0.074 | Prolactin release inhibitor | 0.074 0.017 DBMET00943 | DBMET00943 | |
| 0.18 | 0.19 | 0.301 | Transcription factor NF kappa B inhibitor | 0.301 0.093 DBMET00941 0.295 0.097 DBMET00943 | DBMET00941 | |
| 0.176 | 0.186 | 0.34 | Tyrosine 3 hydroxylase inhibitor | 0.181 0.174 DBMET00941 0.34 0.018 DBMET00943 | DBMET00943 | |
| 0.068 | 0.083 | 0.207 | NMDA receptor antagonist | 0.088 0.055 DBMET00941 0.207 0.013 DBMET00943 | DBMET00943 | |
| 0.017 | 0.032 | 0.038 | Beta 1 adrenoreceptor agonist | 0.034 0.006 DBMET00941 0.038 0.005 DBMET00943 | DBMET00943 | |
| 0.06 | 0.076 | 0.099 | 5 Hydroxytryptamine 2A antagonist | 0.099 0.047 DBMET00943 | DBMET00943 | |
| 0.052 | 0.07 | 0.062 | Leukotriene synthesis inhibitor | 0.062 0.052 DBMET00943 | DBMET00943 | |
| 0.023 | 0.042 | 0.03 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.03 0.029 DBMET00941 | DBMET00941 | |
| 0.031 | 0.057 | 0.047 | Phenylethanolamine N methyltransferase inhibitor | 0.047 0.017 DBMET00943 | DBMET00943 | |
| 0.081 | 0.108 | 0.156 | Chelator | 0.156 0.033 DBMET00943 | DBMET00943 | |
| 0.072 | 0.101 | 0.095 | Hematopoietic | 0.095 0.042 DBMET00941 | DBMET00941 | |
| 0.031 | 0.061 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 DBMET00943 | DBMET00943 | |
| 0.037 | 0.072 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.026 DBMET00941 | DBMET00941 | |
| 0.164 | 0.199 | 0.24 | Hypoxia-inducible factor 1 alpha inhibitor | 0.24 0.11 DBMET00941 | DBMET00941 | |
| 0.037 | 0.072 | 0.052 | Topoisomerase II beta inhibitor | 0.052 0.03 DBMET00941 0.049 0.035 DBMET00943 | DBMET00941 | |
| 0.03 | 0.068 | 0.044 | Opioid mu receptor agonist | 0.044 0.034 DBMET00943 | DBMET00943 | |
| 0.051 | 0.089 | 0.147 | Beta 3 adrenoreceptor antagonist | 0.068 0.038 DBMET00941 0.147 0.006 DBMET00943 | DBMET00943 | |
| 0.031 | 0.07 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.029 DBMET00941 | DBMET00941 | |
| 0.11 | 0.15 | 0.19 | Adenylate cyclase stimulant | 0.127 0.109 DBMET00941 0.19 0.019 DBMET00943 | DBMET00943 | |
| 0.011 | 0.055 | 0.043 | Sigma 2 receptor antagonist | 0.043 0.012 DBMET00943 | DBMET00943 | |
| 0.089 | 0.134 | 0.175 | Nav1.2 sodium channel blocker | 0.122 0.081 DBMET00941 0.175 0.044 DBMET00943 | DBMET00943 | |
| 0.049 | 0.095 | 0.066 | Heme oxygenase stimulant | 0.066 0.033 DBMET00943 | DBMET00943 | |
| 0.083 | 0.13 | 0.119 | Bone formation stimulant | 0.106 0.1 DBMET00941 0.119 0.086 DBMET00943 | DBMET00943 | |
| 0.041 | 0.089 | 0.07 | 5 Hydroxytryptamine 7 agonist | 0.07 0.019 DBMET00943 | DBMET00943 | |
| 0.004 | 0.052 | 0.013 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET00941 0.013 0.007 DBMET00943 | DBMET00943 | |
| 0.081 | 0.129 | 0.12 | Caspase 3 inhibitor | 0.12 0.06 DBMET00941 0.101 0.09 DBMET00943 | DBMET00941 | |
| 0.062 | 0.111 | 0.085 | Histamine H2 receptor antagonist | 0.085 0.056 DBMET00941 0.08 0.066 DBMET00943 | DBMET00941 | |
| 0.171 | 0.221 | 0.452 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.123 DBMET00941 0.452 0.007 DBMET00943 | DBMET00943 | |
| 0.122 | 0.173 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 DBMET00943 | DBMET00943 | |
| 0.033 | 0.085 | 0.103 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET00941 0.103 0.009 DBMET00943 | DBMET00943 | |
| 0.055 | 0.113 | 0.113 | Glycine receptor antagonist | 0.113 0.022 DBMET00943 | DBMET00943 | |
| 0.143 | 0.201 | 0.333 | 5 Hydroxytryptamine 1E antagonist | 0.288 0.038 DBMET00941 0.333 0.014 DBMET00943 | DBMET00943 | |
| 0.056 | 0.115 | 0.197 | MAO A inhibitor | 0.149 0.041 DBMET00941 0.197 0.03 DBMET00943 | DBMET00943 | |
| 0.098 | 0.157 | 0.133 | Vanilloid 1 agonist | 0.133 0.061 DBMET00943 | DBMET00943 | |
| 0.008 | 0.068 | 0.028 | Melatonin 1 antagonist | 0.028 0.007 DBMET00943 | DBMET00943 | |
| 0.024 | 0.084 | 0.05 | NMDA receptor subunit 3B antagonist | 0.05 0.025 DBMET00943 | DBMET00943 | |
| 0.037 | 0.098 | 0.048 | Vanilloid 2 antagonist | 0.048 0.046 DBMET00943 | DBMET00943 | |
| 0.018 | 0.079 | 0.045 | NMDA receptor subunit 3A antagonist | 0.045 0.022 DBMET00943 | DBMET00943 | |
| 0.103 | 0.169 | 0.15 | Platelet adhesion inhibitor | 0.15 0.106 DBMET00941 | DBMET00941 | |
| 0.011 | 0.079 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET00943 | DBMET00943 | |
| 0.061 | 0.13 | 0.199 | Creatine kinase inhibitor | 0.199 0.011 DBMET00943 | DBMET00943 | |
| 0.136 | 0.206 | 0.166 | Hypoglycemic | 0.166 0.153 DBMET00943 | DBMET00943 | |
| 0.077 | 0.147 | 0.221 | Acetylcholinesterase inhibitor | 0.221 0.027 DBMET00943 | DBMET00943 | |
| 0.077 | 0.15 | 0.126 | TRPA1 agonist | 0.126 0.052 DBMET00943 | DBMET00943 | |
| 0.029 | 0.105 | 0.072 | Neuraminidase inhibitor | 0.072 0.032 DBMET00943 | DBMET00943 | |
| 0.069 | 0.145 | 0.203 | Nav1.3 sodium channel blocker | 0.106 0.09 DBMET00941 0.203 0.023 DBMET00943 | DBMET00943 | |
| 0.025 | 0.101 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET00943 | DBMET00943 | |
| 0.043 | 0.12 | 0.134 | Topoisomerase II alpha inhibitor | 0.081 0.052 DBMET00941 0.134 0.026 DBMET00943 | DBMET00943 | |
| 0.034 | 0.111 | 0.11 | Alpha 1 adrenoreceptor antagonist | 0.11 0.04 DBMET00943 | DBMET00943 | |
| 0.018 | 0.097 | 0.042 | Glycine transporter inhibitor | 0.042 0.039 DBMET00943 | DBMET00943 | |
| 0.019 | 0.099 | 0.06 | NMDA 2A receptor antagonist | 0.06 0.029 DBMET00943 | DBMET00943 | |
| 0.014 | 0.094 | 0.025 | Vanilloid 2 agonist | 0.025 0.017 DBMET00943 | DBMET00943 | |
| 0.061 | 0.143 | 0.215 | Topoisomerase II inhibitor | 0.124 0.063 DBMET00941 0.215 0.03 DBMET00943 | DBMET00943 | |
| 0.061 | 0.146 | 0.337 | Anesthetic local | 0.337 0.01 DBMET00943 | DBMET00943 | |
| 0.015 | 0.102 | 0.044 | Melatonin agonist | 0.044 0.012 DBMET00943 | DBMET00943 | |
| 0.121 | 0.208 | 0.217 | Antioxidant | 0.217 0.103 DBMET00943 | DBMET00943 | |
| 0.02 | 0.109 | 0.049 | Potassium channel Kv1.3 blocker | 0.049 0.03 DBMET00943 | DBMET00943 | |
| 0.033 | 0.123 | 0.05 | Thromboxane synthase inhibitor | 0.05 0.047 DBMET00943 | DBMET00943 | |
| 0.064 | 0.155 | 0.099 | Proteasome inhibitor | 0.099 0.089 DBMET00943 | DBMET00943 | |
| 0.13 | 0.225 | 0.546 | 5 Hydroxytryptamine release stimulant | 0.546 0.021 DBMET00943 | DBMET00943 | |
| 0.052 | 0.15 | 0.085 | Vanilloid 4 agonist | 0.085 0.033 DBMET00943 | DBMET00943 | |
| 0.042 | 0.143 | 0.08 | Ornithine decarboxylase inhibitor | 0.08 0.067 DBMET00943 | DBMET00943 | |
| 0.04 | 0.145 | 0.061 | Interferon inducer | 0.061 0.051 DBMET00943 | DBMET00943 | |
| 0.02 | 0.126 | 0.041 | Sphingosine 1-phosphate receptor agonist | 0.041 0.035 DBMET00943 | DBMET00943 | |
| 0.015 | 0.123 | 0.074 | Cannabinoid CB2 receptor antagonist | 0.074 0.022 DBMET00943 | DBMET00943 | |
| 0.027 | 0.137 | 0.07 | Antineoplastic antibiotic | 0.07 0.065 DBMET00943 | DBMET00943 | |
| 0.102 | 0.213 | 0.404 | Antiamyloidogenic | 0.404 0.028 DBMET00943 | DBMET00943 | |
| 0.061 | 0.173 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.027 DBMET00943 | DBMET00943 | |
| 0.027 | 0.138 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 DBMET00943 | DBMET00943 | |
| 0.043 | 0.158 | 0.08 | Interferon agonist | 0.08 0.052 DBMET00943 | DBMET00943 | |
| 0.016 | 0.132 | 0.088 | Glycine transporter 2 inhibitor | 0.088 0.015 DBMET00943 | DBMET00943 | |
| 0.015 | 0.132 | 0.059 | Carbonic anhydrase VB inhibitor | 0.059 0.036 DBMET00941 | DBMET00941 | |
| 0.119 | 0.236 | 0.26 | Prostaglandin dehydrogenase inhibitor | 0.26 0.122 DBMET00941 | DBMET00941 | |
| 0.043 | 0.161 | 0.064 | MAP kinase kinase 8 inhibitor | 0.064 0.054 DBMET00941 | DBMET00941 | |
| 0.005 | 0.124 | 0.018 | Melatonin receptor 1A antagonist | 0.018 0.006 DBMET00943 | DBMET00943 | |
| 0.058 | 0.177 | 0.091 | Electrolyte absorption antagonist | 0.091 0.071 DBMET00943 | DBMET00943 | |
| 0.024 | 0.147 | 0.117 | 5 Hydroxytryptamine 2A agonist | 0.117 0.01 DBMET00943 | DBMET00943 | |
| 0.015 | 0.139 | 0.061 | Alpha 1d adrenoreceptor antagonist | 0.061 0.04 DBMET00943 | DBMET00943 | |
| 0.054 | 0.178 | 0.113 | Anabolic | 0.113 0.046 DBMET00943 | DBMET00943 | |
| 0.026 | 0.151 | 0.06 | Androgen agonist | 0.06 0.041 DBMET00943 | DBMET00943 | |
| 0.022 | 0.147 | 0.05 | Histamine H1 receptor agonist | 0.05 0.019 DBMET00943 | DBMET00943 | |
| 0.082 | 0.208 | 0.154 | Heat shock protein 90 antagonist | 0.154 0.071 DBMET00943 | DBMET00943 | |
| 0.03 | 0.156 | 0.068 | Neuraminidase (influenza) inhibitor | 0.068 0.038 DBMET00943 | DBMET00943 | |
| 0.131 | 0.257 | 0.297 | Cholesterol antagonist | 0.297 0.093 DBMET00943 | DBMET00943 | |
| 0.074 | 0.2 | 0.228 | Cholinergic | 0.228 0.035 DBMET00943 | DBMET00943 | |
| 0.015 | 0.142 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.018 DBMET00943 | DBMET00943 | |
| 0.066 | 0.194 | 0.119 | Photosensitizer | 0.119 0.058 DBMET00943 | DBMET00943 | |
| 0.181 | 0.31 | 0.363 | MAP kinase kinase 6 inhibitor | 0.363 0.082 DBMET00941 0.266 0.17 DBMET00943 | DBMET00941 | |
| 0.019 | 0.149 | 0.054 | 5 Hydroxytryptamine 2 agonist | 0.054 0.033 DBMET00943 | DBMET00943 | |
| 0.043 | 0.174 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.073 DBMET00943 | DBMET00943 | |
| 0.057 | 0.188 | 0.129 | AMP-activated protein kinase stimulant | 0.129 0.042 DBMET00943 | DBMET00943 | |
| 0.011 | 0.144 | 0.05 | Carbonic anhydrase VII inhibitor | 0.05 0.027 DBMET00941 | DBMET00941 | |
| 0.045 | 0.18 | 0.186 | MAO inhibitor | 0.129 0.07 DBMET00941 0.186 0.045 DBMET00943 | DBMET00943 | |
| 0.031 | 0.167 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.033 DBMET00943 | DBMET00943 | |
| 0.016 | 0.153 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET00943 | DBMET00943 | |
| 0.017 | 0.161 | 0.098 | Alpha 1a adrenoreceptor antagonist | 0.098 0.037 DBMET00943 | DBMET00943 | |
| 0.019 | 0.163 | 0.059 | Sphingosine kinase 1 inhibitor | 0.059 0.01 DBMET00943 | DBMET00943 | |
| 0.006 | 0.151 | 0.022 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DBMET00941 | DBMET00941 | |
| 0.088 | 0.234 | 0.164 | P-glycoprotein inhibitor | 0.164 0.097 DBMET00943 | DBMET00943 | |
| 0.135 | 0.282 | 0.24 | Alpha-glucosidase inhibitor | 0.24 0.193 DBMET00941 | DBMET00941 | |
| 0.091 | 0.24 | 0.293 | Immunostimulant | 0.293 0.08 DBMET00943 | DBMET00943 | |
| 0.048 | 0.198 | 0.096 | Cholesterol synthesis inhibitor | 0.096 0.093 DBMET00943 | DBMET00943 | |
| 0.013 | 0.164 | 0.032 | Melatonin 1 agonist | 0.032 0.025 DBMET00943 | DBMET00943 | |
| 0.031 | 0.181 | 0.071 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.071 0.06 DBMET00943 | DBMET00943 | |
| 0.115 | 0.267 | 0.177 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.177 0.098 DBMET00943 | DBMET00943 | |
| 0.045 | 0.198 | 0.145 | Aminoacyl-tRNA synthetase inhibitor | 0.094 0.053 DBMET00941 0.145 0.02 DBMET00943 | DBMET00943 | |
| 0.028 | 0.184 | 0.09 | Carbonic anhydrase XIII inhibitor | 0.09 0.043 DBMET00941 | DBMET00941 | |
| 0.078 | 0.237 | 0.149 | Heat shock protein 90 alpha antagonist | 0.149 0.087 DBMET00943 | DBMET00943 | |
| 0.095 | 0.255 | 0.157 | Lipocortins synthesis antagonist | 0.157 0.095 DBMET00943 | DBMET00943 | |
| 0.024 | 0.185 | 0.072 | Carbonic anhydrase VA inhibitor | 0.072 0.044 DBMET00941 | DBMET00941 | |
| 0.026 | 0.19 | 0.086 | Sphingosine kinase inhibitor | 0.086 0.013 DBMET00943 | DBMET00943 | |
| 0.031 | 0.199 | 0.109 | Protein kinase (CK2) inhibitor | 0.109 0.056 DBMET00941 | DBMET00941 | |
| 0.097 | 0.265 | 0.183 | Calpain inhibitor | 0.168 0.152 DBMET00941 0.183 0.131 DBMET00943 | DBMET00943 | |
| 0.026 | 0.194 | 0.052 | Epithelial sodium channel blocker | 0.052 0.044 DBMET00943 | DBMET00943 | |
| 0.017 | 0.185 | 0.056 | Acetylcholine M5 receptor antagonist | 0.056 0.049 DBMET00943 | DBMET00943 | |
| 0.034 | 0.203 | 0.073 | I kappa B kinase inhibitor | 0.073 0.072 DBMET00943 | DBMET00943 | |
| 0.124 | 0.295 | 0.2 | Immunosuppressant | 0.2 0.198 DBMET00943 | DBMET00943 | |
| 0.02 | 0.191 | 0.049 | Neuropeptide Y5 antagonist | 0.049 0.038 DBMET00943 | DBMET00943 | |
| 0.018 | 0.19 | 0.039 | 5 Hydroxytryptamine 2B agonist | 0.039 0.026 DBMET00943 | DBMET00943 | |
| 0.067 | 0.24 | 0.137 | Pyruvate kinase inhibitor | 0.137 0.127 DBMET00941 | DBMET00941 | |
| 0.034 | 0.208 | 0.108 | Protein kinase (CK2) alpha inhibitor | 0.108 0.07 DBMET00941 | DBMET00941 | |
| 0.057 | 0.233 | 0.572 | Psychostimulant | 0.572 0.007 DBMET00943 | DBMET00943 | |
| 0.021 | 0.198 | 0.114 | MAO B inhibitor | 0.114 0.053 DBMET00943 | DBMET00943 | |
| 0.079 | 0.259 | 0.471 | Aldehyde oxidase inhibitor | 0.471 0.037 DBMET00943 | DBMET00943 | |
| 0.128 | 0.31 | 0.237 | Antiobesity | 0.237 0.169 DBMET00943 | DBMET00943 | |
| 0.042 | 0.225 | 0.181 | GABA C receptor agonist | 0.181 0.024 DBMET00943 | DBMET00943 | |
| 0.12 | 0.306 | 0.203 | Peptidyltransferase inhibitor | 0.203 0.096 DBMET00943 | DBMET00943 | |
| 0.026 | 0.212 | 0.059 | I kappa B kinase 2 inhibitor | 0.058 0.052 DBMET00941 0.059 0.048 DBMET00943 | DBMET00943 | |
| 0.019 | 0.207 | 0.061 | Carbonic anhydrase V inhibitor | 0.061 0.053 DBMET00941 | DBMET00941 | |
| 0.128 | 0.317 | 0.257 | Transcription factor inhibitor | 0.257 0.181 DBMET00941 | DBMET00941 | |
| 0.005 | 0.195 | 0.03 | Epoxide hydrolase 2 inhibitor | 0.03 0.014 DBMET00943 | DBMET00943 | |
| 0.015 | 0.207 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.028 DBMET00943 | DBMET00943 | |
| 0.008 | 0.2 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET00943 | DBMET00943 | |
| 0.021 | 0.214 | 0.046 | Cytokine production stimulant | 0.046 0.04 DBMET00943 | DBMET00943 | |
| 0.083 | 0.278 | 0.212 | CF transmembrane conductance regulator agonist | 0.212 0.016 DBMET00943 | DBMET00943 | |
| 0.044 | 0.246 | 0.179 | Nav1.6 sodium channel blocker | 0.179 0.029 DBMET00943 | DBMET00943 | |
| 0.015 | 0.218 | 0.074 | Alpha 1 adrenoreceptor agonist | 0.074 0.025 DBMET00943 | DBMET00943 | |
| 0.024 | 0.23 | 0.053 | MAP kinase kinase 9 inhibitor | 0.053 0.043 DBMET00941 | DBMET00941 | |
| 0.003 | 0.21 | 0.015 | CXC chemokine 4 receptor agonist | 0.015 0.01 DBMET00943 | DBMET00943 | |
| 0.037 | 0.244 | 0.13 | Neuropeptide Y antagonist | 0.13 0.026 DBMET00943 | DBMET00943 | |
| 0.043 | 0.252 | 0.132 | Histone deacetylase class III inhibitor | 0.132 0.059 DBMET00941 | DBMET00941 | |
| 0.021 | 0.23 | 0.086 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 DBMET00941 0.086 0.01 DBMET00943 | DBMET00943 | |
| 0.017 | 0.227 | 0.045 | Adenylate cyclase 1 inhibitor | 0.045 0.034 DBMET00943 | DBMET00943 | |
| 0.044 | 0.255 | 0.1 | MAP kinase kinase 7 inhibitor | 0.1 0.013 DBMET00943 | DBMET00943 | |
| 0.036 | 0.247 | 0.089 | ATPase (Vacuolar H+) inhibitor | 0.089 0.059 DBMET00943 | DBMET00943 | |
| 0.062 | 0.276 | 0.149 | Arachidonic acid antagonist | 0.149 0.09 DBMET00943 | DBMET00943 | |
| 0.021 | 0.235 | 0.09 | Histone deacetylase SIRT2 inhibitor | 0.09 0.037 DBMET00941 | DBMET00941 | |
| 0.02 | 0.237 | 0.045 | DNA gyrase subunit A inhibitor | 0.045 0.025 DBMET00943 | DBMET00943 | |
| 0.07 | 0.289 | 0.154 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.154 0.138 DBMET00941 | DBMET00941 | |
| 0.054 | 0.274 | 0.102 | CC chemokine 5 receptor agonist | 0.102 0.02 DBMET00943 | DBMET00943 | |
| 0.071 | 0.293 | 0.136 | Growth hormone agonist | 0.136 0.1 DBMET00943 | DBMET00943 | |
| 0.003 | 0.226 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET00943 | DBMET00943 | |
| 0.052 | 0.275 | 0.298 | Amyloid beta aggregation inhibitor | 0.298 0.046 DBMET00943 | DBMET00943 | |
| 0.026 | 0.253 | 0.173 | Butyrylcholinesterase inhibitor | 0.173 0.027 DBMET00943 | DBMET00943 | |
| 0.107 | 0.336 | 0.239 | RNA-directed DNA polymerase inhibitor | 0.239 0.056 DBMET00943 | DBMET00943 | |
| 0.009 | 0.242 | 0.114 | NMDA 2 receptor antagonist | 0.114 0.026 DBMET00943 | DBMET00943 | |
| 0.024 | 0.26 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 DBMET00943 | DBMET00943 | |
| 0.07 | 0.308 | 0.139 | Melanin inhibitor | 0.139 0.099 DBMET00943 | DBMET00943 | |
| 0.042 | 0.281 | 0.146 | Carbonic anhydrase III inhibitor | 0.088 0.077 DBMET00941 0.146 0.03 DBMET00943 | DBMET00943 | |
| 0.012 | 0.259 | 0.084 | Carbonic anhydrase XIV inhibitor | 0.084 0.015 DBMET00943 | DBMET00943 | |
| 0.009 | 0.257 | 0.111 | NMDA 2C receptor antagonist | 0.111 0.013 DBMET00943 | DBMET00943 | |
| 0.018 | 0.266 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.068 0.028 DBMET00943 | DBMET00943 | |
| 0.027 | 0.276 | 0.091 | Histamine N-methyltransferase inhibitor | 0.091 0.054 DBMET00943 | DBMET00943 | |
| 0.11 | 0.36 | 0.293 | Sodium/bile acid cotransporter inhibitor | 0.293 0.086 DBMET00943 | DBMET00943 | |
| 0.114 | 0.367 | 0.267 | Antibacterial | 0.267 0.161 DBMET00943 | DBMET00943 | |
| 0.035 | 0.289 | 0.24 | GABA C receptor antagonist | 0.24 0.007 DBMET00943 | DBMET00943 | |
| 0.037 | 0.298 | 0.213 | GABA C receptor rho-1 antagonist | 0.213 0.006 DBMET00943 | DBMET00943 | |
| 0.028 | 0.297 | 0.085 | Aminopeptidase B inhibitor | 0.085 0.077 DBMET00943 | DBMET00943 | |
| 0.021 | 0.292 | 0.071 | Potassium channel (ATP-sensitive) blocker | 0.071 0.039 DBMET00943 | DBMET00943 | |
| 0.046 | 0.32 | 0.127 | Cyclooxygenase 3 inhibitor | 0.127 0.07 DBMET00943 | DBMET00943 | |
| 0.007 | 0.285 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET00943 | DBMET00943 | |
| 0.049 | 0.326 | 0.312 | Peroxidase inhibitor | 0.312 0.035 DBMET00943 | DBMET00943 | |
| 0.05 | 0.328 | 0.124 | Interleukin 4 antagonist | 0.124 0.08 DBMET00943 | DBMET00943 | |
| 0.145 | 0.427 | 0.379 | Caspase 9 stimulant | 0.379 0.124 DBMET00943 | DBMET00943 | |
| 0.022 | 0.306 | 0.089 | GABA aminotransferase inhibitor | 0.089 0.036 DBMET00943 | DBMET00943 | |
| 0.032 | 0.32 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.07 DBMET00943 | DBMET00943 | |
| 0.07 | 0.36 | 0.224 | Neurotrophic factor enhancer | 0.224 0.056 DBMET00943 | DBMET00943 | |
| 0.138 | 0.433 | 0.38 | Calcium channel L-type activator | 0.38 0.095 DBMET00943 | DBMET00943 | |
| 0.028 | 0.324 | 0.101 | Carbonic anhydrase VI inhibitor | 0.101 0.038 DBMET00943 | DBMET00943 | |
| 0.07 | 0.372 | 0.215 | Phospholipase C inhibitor | 0.215 0.035 DBMET00943 | DBMET00943 | |
| 0.049 | 0.368 | 0.191 | Neuropeptide Y1 antagonist | 0.191 0.023 DBMET00943 | DBMET00943 | |
| 0.045 | 0.368 | 0.171 | Anticonvulsant | 0.171 0.107 DBMET00943 | DBMET00943 | |
| 0.071 | 0.395 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.182 0.022 DBMET00943 | DBMET00943 | |
| 0.027 | 0.354 | 0.067 | Glycine receptor agonist | 0.067 0.062 DBMET00943 | DBMET00943 | |
| 0.019 | 0.351 | 0.088 | Heat shock protein 90 beta antagonist | 0.088 0.016 DBMET00943 | DBMET00943 | |
| 0.036 | 0.369 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.045 DBMET00943 | DBMET00943 | |
| 0.037 | 0.373 | 0.125 | Diuretic | 0.125 0.099 DBMET00943 | DBMET00943 | |
| 0.039 | 0.376 | 0.104 | Nav1.1 sodium channel blocker | 0.104 0.062 DBMET00943 | DBMET00943 | |
| 0.022 | 0.36 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET00943 | DBMET00943 | |
| 0.052 | 0.391 | 0.189 | Antipruritic | 0.189 0.057 DBMET00943 | DBMET00943 | |
| 0.031 | 0.382 | 0.163 | Alpha-N-acetylglucosaminidase inhibitor | 0.163 0.048 DBMET00943 | DBMET00943 | |
| 0.093 | 0.445 | 0.481 | GABA C receptor rho-3 antagonist | 0.481 0.031 DBMET00943 | DBMET00943 | |
| 0.026 | 0.378 | 0.089 | Sphingomyelinase inhibitor | 0.089 0.073 DBMET00943 | DBMET00943 | |
| 0.02 | 0.378 | 0.126 | Alkylator | 0.126 0.063 DBMET00943 | DBMET00943 | |
| 0.043 | 0.413 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.101 DBMET00943 | DBMET00943 | |
| 0.034 | 0.405 | 0.118 | Toll-Like receptor 2 antagonist | 0.118 0.08 DBMET00943 | DBMET00943 | |
| 0.031 | 0.411 | 0.118 | Toll-Like receptor antagonist | 0.118 0.087 DBMET00943 | DBMET00943 | |
| 0.002 | 0.389 | 0.017 | Cyclin T1 inhibitor | 0.017 0.014 DBMET00943 | DBMET00943 | |
| 0.095 | 0.487 | 0.251 | Apoptosis agonist | 0.251 0.213 DBMET00943 | DBMET00943 | |
| 0.086 | 0.478 | 0.207 | Apoptosis antagonist | 0.207 0.17 DBMET00943 | DBMET00943 | |
| 0.046 | 0.439 | 0.158 | Succinate dehydrogenase inhibitor | 0.158 0.099 DBMET00943 | DBMET00943 | |
| 0.01 | 0.404 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 DBMET00943 | DBMET00943 | |
| 0.043 | 0.439 | 0.157 | Sphingosine 1-phosphate receptor 2 antagonist | 0.157 0.033 DBMET00943 | DBMET00943 | |
| 0.013 | 0.411 | 0.039 | Potassium channel Kv1.1 blocker | 0.039 0.025 DBMET00943 | DBMET00943 | |
| 0.029 | 0.433 | 0.127 | Amylase inhibitor | 0.127 0.077 DBMET00943 | DBMET00943 | |
| 0.071 | 0.477 | 0.228 | Histamine release inhibitor | 0.228 0.173 DBMET00943 | DBMET00943 | |
| 0.064 | 0.477 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.125 DBMET00943 | DBMET00943 | |
| 0.007 | 0.425 | 0.035 | Delayed rectifier potassium channel blocker | 0.035 0.031 DBMET00943 | DBMET00943 | |
| 0.047 | 0.469 | 0.171 | Cyclic AMP phosphodiesterase inhibitor | 0.171 0.121 DBMET00943 | DBMET00943 | |
| 0.056 | 0.479 | 0.231 | Superoxide dismutase inhibitor | 0.231 0.088 DBMET00943 | DBMET00943 | |
| 0.062 | 0.49 | 0.23 | Gastrin inhibitor | 0.23 0.105 DBMET00943 | DBMET00943 | |
| 0.07 | 0.499 | 0.298 | Vasodilator, coronary | 0.298 0.089 DBMET00943 | DBMET00943 | |
| 0.007 | 0.44 | 0.046 | Mannosidase inhibitor | 0.046 0.03 DBMET00943 | DBMET00943 | |
| 0.014 | 0.448 | 0.066 | Botulinum neurotoxin type A inhibitor | 0.066 0.03 DBMET00943 | DBMET00943 | |
| 0.034 | 0.475 | 0.165 | Glutamate (mGluR7) agonist | 0.165 0.008 DBMET00943 | DBMET00943 | |
| 0.1 | 0.546 | 0.187 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.088 DBMET00943 | DBMET00943 | |
| 0.042 | 0.501 | 0.215 | DNA damaging | 0.215 0.104 DBMET00943 | DBMET00943 | |
| 0.037 | 0.514 | 0.168 | GABA C receptor rho-2 antagonist | 0.168 0.053 DBMET00943 | DBMET00943 | |
| 0.007 | 0.505 | 0.079 | Epoxide hydrolase inhibitor | 0.079 0.043 DBMET00943 | DBMET00943 | |
| 0.035 | 0.538 | 0.212 | Interleukin agonist | 0.212 0.11 DBMET00943 | DBMET00943 | |
| 0.029 | 0.548 | 0.218 | DNA synthesis inhibitor | 0.218 0.097 DBMET00943 | DBMET00943 | |
| 0.064 | 0.586 | 0.255 | Calcium channel activator | 0.255 0.141 DBMET00943 | DBMET00943 | |
| 0.014 | 0.558 | 0.118 | DNA intercalator | 0.118 0.059 DBMET00943 | DBMET00943 | |
| 0.072 | 0.634 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.163 DBMET00943 | DBMET00943 | |
| 0.03 | 0.602 | 0.154 | ATPase inhibitor | 0.154 0.095 DBMET00943 | DBMET00943 | |
| 0.046 | 0.66 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.164 0.078 DBMET00943 | DBMET00943 | |
| 0.029 | 0.66 | 0.211 | Neuropeptide Y2 antagonist | 0.211 0.101 DBMET00943 | DBMET00943 | |
| 0.01 | 0.668 | 0.081 | Myeloperoxidase inhibitor | 0.081 0.065 DBMET00943 | DBMET00943 | |
| 0.015 | 0.686 | 0.059 | Parathyroid hormone antagonist | 0.043 0.037 DBMET00941 0.059 0.012 DBMET00943 | DBMET00943 | |
| 0.059 | 0.818 | 0.286 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.286 0.232 DBMET00943 | DBMET00943 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |